This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
210 Broadway Suite 201
Cambridge, Massachusetts 02139
Founded in 2000 as a spin-off from the University of T?bingen in Germany, CureVac is a technology leader in the development of drugs that are based on the Messenger RNA (mRNA) molecule. The company has an extensive expertise in handling and optimizing thi ... more
Research Assistant and Author
Dr. Cynthia Meyer, Counseling Skills
Waukesha Family Ymca
MBA Fellow, Executive Ass. To Chief Executive Officer
Advisory Board Member
Europe Unlimited S.A
January 2013-May 2014 Active Member, Secretary 2013-2014 School Year
Family Social Sciences Round Table
Danube University of Krems
University of Tübingen
CureVac launches Phase IIa mRNA vaccine trial in prostate cancer
P.J. Hoerr , Inc.
University of Wisconsin System
Phelps County Regional Medical Center